Back

Discussion

2 September 2019 (10:39 - 10:45)
Organised by:
Congress Presentation Part of: Combinations of beta-blockers and angiotensin-converting enzyme inhibitors: what is the rationale? Treatment ESC Premium Access ESC Congress 2019

About the speakers

Photo
Professor Christoph Maack

University Clinic Wuerzburg, Wuerzburg (Germany)

Photo
Doctor Jacek Wolf

Gdansk (Poland)

Photo
Professor Konstantinos Tsioufis

National & Kapodistrian University of Athens Medical School, Athens (Greece)

2 More presentations in this session

Presentation thumbnail
Beta-blockers in hypertensive patients with comorbidities: where do we stand?
Professor C. Maack (Wuerzburg, DE)
Slides Video
Presentation thumbnail
Combinations of beta-blockers and angiotensin-converting enzyme inhibitors: Why, when and for whom are they in line with the guidelines?
Doctor J. Wolf (Gdansk, PL)
Slides Video

Access the full session

Session thumbnail
Combinations of beta-blockers and angiotensin-converting enzyme inhibitors: what is the rationale?

The Event

Event poster

ESC Congress 2019

2 September 2019 10:39 CET
You may be interested in
thumbnail
Congress Session
The EHJ’s year in cardiovascular medicine: cardio-oncology, heart failure, and arrhythmias
26 August 2023
thumbnail
Congress Session
Evolving treatment paradigms in heart failure: from SGLT2 inhibition to transthyretin stabilisation and beyond
20 May 2025
thumbnail
Congress Presentation
Introduction
30 August 2025
thumbnail
Webinar
Percutaneous interventions in patients with coronary artery disease and specific clinical conditions - IC Core Curriculum 6
9 November 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources